Skip to main content
DrugPrice

Ranolazine

Ranolazine

Generic availableOtherby Gilead
$96.00
avg cost per claim
-8.6% year-over-year
$178.0M
Medicare Spending
1,860,000
Total Claims
224,000
Beneficiaries
$795.00
Annual Cost/Patient

Why Ranolazine Costs $96.00 Per Claim

Ranolazine (Ranolazine) is used to treat other. According to CMS Medicare Part D spending data, the program spent $178.0M on this drug, covering 224,000 beneficiaries across 1,860,000 claims.

A generic version of this drug is available, which means lower-cost alternatives exist. Patients should ask their pharmacist about generic Ranolazine or talk to their doctor about therapeutic alternatives that may cost less.

Price Breakdown

Avg cost per claim (30-day)$96.00
Avg annual cost per patient$795.00
Total Medicare spending$178.0M
Total claims1,860,000
Beneficiaries224,000

Drug Details

Brand Name
Ranolazine
Generic Name
Ranolazine
Active Ingredient
Ranolazine
Manufacturer
Gilead
Dosage Form
N/A
Route
N/A
Condition
Other
FDA Application
BLA125057

Frequently Asked Questions

Ranolazine (Ranolazine) costs an average of $96.00 per claim based on Medicare Part D data. The estimated annual cost per patient is $795.00. Actual out-of-pocket costs depend on your insurance plan and pharmacy.

Yes, a generic version of Ranolazine (Ranolazine) is available. Generic medications typically cost 80-95% less than brand-name drugs. Ask your pharmacist about generic Ranolazine.

Medicare Part D spent $178.0M on Ranolazine, covering 224,000 beneficiaries across 1,860,000 claims. This makes it one of the tracked drugs in the Medicare spending dashboard.

Ask your pharmacist about generic Ranolazine, which is typically much cheaper. You can also compare prices at different pharmacies, use prescription discount programs, or ask your doctor about therapeutic alternatives in the same drug class.

Cost data reflects Medicare Part D spending and may not represent retail pharmacy prices. Average cost per claim represents the total drug cost (not patient out-of-pocket) divided by total claims.